Filtros de búsqueda

Lista de obras de

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

scientific article published on 22 December 2019

A phase 2B randomised trial of hyperbaric oxygen therapy for ulcerative colitis patients hospitalised for moderate to severe flares

artículo científico publicado en 2020

Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases

scientific article published on 19 June 2019

Assessment of mucosal healing in inflammatory bowel disease: review.

artículo científico

Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease

scientific article published on 13 July 2020

Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease.

artículo científico publicado en 2017

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis

artículo científico publicado en 2020

Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT

scientific article published on 19 March 2019

Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era-getting nearer? Authors' reply

scientific article published on 01 April 2020

Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease

scientific article published on 24 April 2020

Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study

scientific article published on 27 September 2020

High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis

artículo científico publicado en 2018

Innovations in Oral Therapies for Inflammatory Bowel Disease

scientific article published on 01 August 2019

Letter: combination of biologics in inflammatory bowel diseases. Authors' reply

scientific article published on 01 August 2020

MRI scoring indices for evaluation of disease activity and severity in Crohn’s disease

artículo científico publicado en 2015

Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.

artículo científico publicado en 2017

No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy

artículo científico publicado en 2020

Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s disease

artículo científico publicado en 2016

Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis

artículo científico publicado en 2017

Placebo response and remission rates in randomized trials of induction and maintenance therapy for ulcerative colitis

artículo científico publicado en 2015

Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing

scientific article published on 09 August 2020

Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis

scientific article published on 22 November 2019

Risk of de-novo inflammatory bowel disease among obese patients treated with bariatric surgery or weight loss medications

artículo científico publicado en 2020

Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis

artículo científico publicado en 2016

Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases

scientific article published on 04 September 2019

Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda